PL374818A1 - Pochodne oksazolu i ich zastosowanie jako środkówuwrażliwiających na insulinę - Google Patents

Pochodne oksazolu i ich zastosowanie jako środkówuwrażliwiających na insulinę

Info

Publication number
PL374818A1
PL374818A1 PL03374818A PL37481803A PL374818A1 PL 374818 A1 PL374818 A1 PL 374818A1 PL 03374818 A PL03374818 A PL 03374818A PL 37481803 A PL37481803 A PL 37481803A PL 374818 A1 PL374818 A1 PL 374818A1
Authority
PL
Poland
Prior art keywords
insulin sensitizers
oxazole derivatives
oxazole
sensitizers
insulin
Prior art date
Application number
PL03374818A
Other languages
English (en)
Inventor
Bernd Brodbeck
Hans Hilpert
Roland Humm
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL374818A1 publication Critical patent/PL374818A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03374818A 2002-07-03 2003-06-26 Pochodne oksazolu i ich zastosowanie jako środkówuwrażliwiających na insulinę PL374818A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02014828 2002-07-03

Publications (1)

Publication Number Publication Date
PL374818A1 true PL374818A1 (pl) 2005-10-31

Family

ID=29797151

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374818A PL374818A1 (pl) 2002-07-03 2003-06-26 Pochodne oksazolu i ich zastosowanie jako środkówuwrażliwiających na insulinę

Country Status (16)

Country Link
US (1) US6747049B2 (pl)
EP (1) EP1519925B1 (pl)
JP (1) JP4290648B2 (pl)
KR (1) KR100621294B1 (pl)
CN (1) CN100402510C (pl)
AR (1) AR040359A1 (pl)
AT (1) ATE372990T1 (pl)
AU (1) AU2003249879B2 (pl)
BR (1) BR0312452A (pl)
CA (1) CA2490152C (pl)
DE (1) DE60316290T2 (pl)
ES (1) ES2291688T3 (pl)
MX (1) MXPA04012840A (pl)
PL (1) PL374818A1 (pl)
RU (1) RU2295520C2 (pl)
WO (1) WO2004005266A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1533292B1 (en) * 2002-08-30 2007-02-14 Japan Tobacco Inc. Dibenzylamine compound and medicinal use thereof
CN101007790B (zh) * 2006-01-27 2011-03-30 北京摩力克科技有限公司 草氨酸衍生物、其制备方法和医药用途
CA2640608A1 (en) * 2006-02-01 2007-08-09 Merck & Co., Inc. Potassium channel inhibitors
EP3478297A1 (en) 2016-06-30 2019-05-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of cardiomyopathies
WO2020201263A1 (en) 2019-04-01 2020-10-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment and prevention of cardiac remodeling

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011326A (en) 1975-07-29 1977-03-08 Merck & Co., Inc. 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
TW222626B (pl) * 1991-07-22 1994-04-21 Pfizer
GB9225386D0 (en) 1992-12-04 1993-01-27 Smithkline Beecham Plc Novel compounds
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
GB9326171D0 (en) 1993-12-22 1994-02-23 Smithkline Beecham Plc Novel compounds
GB9600464D0 (en) 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
DE69731562T2 (de) 1996-12-10 2005-11-24 Bristol-Myers Squibb Co., Wallingford Benzodioxol, benzofuran, dihydrobenzofuran und benzodioxan melatonergische agentien
DE19711616A1 (de) 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
US6121397A (en) 1997-07-14 2000-09-19 Xerox Corporation Polymerization processes using oligomeric compound, monomer and surfactant
HN1998000118A (es) 1997-08-27 1999-02-09 Pfizer Prod Inc 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
DE69815008T2 (de) 1997-09-19 2004-04-01 Ssp Co., Ltd. Alfa-substituierte Phenylpropionsäurederivate und diese enthaltende Arzneimittel
CN1208326C (zh) 1998-04-23 2005-06-29 雷迪实验室有限公司 杂环化合物及其在医药方面的应用、其制备方法及含有它们的药物组合物
GB9817118D0 (en) 1998-08-07 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
GB9914977D0 (en) * 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
ES2258431T3 (es) 1999-08-02 2006-09-01 F. Hoffmann-La Roche Ag Proceso para la preparacion de derivados de benzotiofeno.
BR0113409A (pt) 2000-08-23 2003-07-01 Lilly Co Eli Agonistas de receptores ativados por proliferadores de peroxissomas

Also Published As

Publication number Publication date
CA2490152C (en) 2009-04-07
WO2004005266A1 (en) 2004-01-15
AU2003249879A1 (en) 2004-01-23
MXPA04012840A (es) 2005-02-24
RU2005102817A (ru) 2005-11-20
CN100402510C (zh) 2008-07-16
EP1519925B1 (en) 2007-09-12
US20040006116A1 (en) 2004-01-08
EP1519925A1 (en) 2005-04-06
CN1668606A (zh) 2005-09-14
KR100621294B1 (ko) 2006-09-06
JP2005535647A (ja) 2005-11-24
AR040359A1 (es) 2005-03-30
JP4290648B2 (ja) 2009-07-08
KR20050025303A (ko) 2005-03-14
DE60316290T2 (de) 2008-06-12
BR0312452A (pt) 2005-04-19
RU2295520C2 (ru) 2007-03-20
CA2490152A1 (en) 2004-01-15
AU2003249879B2 (en) 2008-12-18
ES2291688T3 (es) 2008-03-01
DE60316290D1 (de) 2007-10-25
ATE372990T1 (de) 2007-09-15
US6747049B2 (en) 2004-06-08

Similar Documents

Publication Publication Date Title
CY2013027I1 (el) Νεα παραγωγα ινσουλινης
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
IL166624A0 (en) Taxane derivatives
PL372123A1 (pl) Pochodne tiazolu
PL1648874T3 (pl) Pochodne piperazyny i ich zastosowanie jako środków leczniczych
AP2004003110A0 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
AU2003249909A1 (en) Phenoxypropenylphenyl derivatives and their use as herbicides
SI2107069T1 (sl) Novi inzulinski derivati
PL1694649T3 (pl) Pochodne 2-pirydynyloetylokarboksyamidu i ich zastosowanie jako fungicydów
IL206050A0 (en) Oxazole derivatives of tetracyclines
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
AU2003292422A1 (en) Oxazolidinone derivatives and their use as antibacterial agents
IL177047A0 (en) Oxazole derivatives, preparation and therapeutic use thereof
PL375416A1 (pl) Pochodne tiazolu
MY145576A (en) Benzoxazine derivatives and uses thereof
AU2003292381A1 (en) Naphthyridine derivatives and their use as fungicides
IL178259A0 (en) Novel benzothiazoles and the use thereof as medicaments
AU2003209728A1 (en) Cyclopentene derivatives
PL374818A1 (pl) Pochodne oksazolu i ich zastosowanie jako środkówuwrażliwiających na insulinę
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003232785A1 (en) Novel anthracene derivatives and the use thereof as a medicament
PL377711A1 (pl) Pochodne karboksyamidowe i ich zastosowanie jako inhibitorów czynnika Xa
GB0316910D0 (en) Fluorocombretastatin and derivatives thereof
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)